Brestoff Jonathan R, Artis David
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY, 10021, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY, 10021, USA.
Cell. 2015 Mar 26;161(1):146-160. doi: 10.1016/j.cell.2015.02.022.
Obesity is an increasingly prevalent disease worldwide. While genetic and environmental factors are known to regulate the development of obesity and associated metabolic diseases, emerging studies indicate that innate and adaptive immune cell responses in adipose tissue have critical roles in the regulation of metabolic homeostasis. In the lean state, type 2 cytokine-associated immune cell responses predominate in white adipose tissue and protect against weight gain and insulin resistance through direct effects on adipocytes and elicitation of beige adipose. In obesity, these metabolically beneficial immune pathways become dysregulated, and adipocytes and other factors initiate metabolically deleterious type 1 inflammation that impairs glucose metabolism. This review discusses our current understanding of the functions of different types of adipose tissue and how immune cells regulate adipocyte function and metabolic homeostasis in the context of health and disease and highlights. We also highlight the potential of targeting immuno-metabolic pathways as a therapeutic strategy to treat obesity and associated diseases.
肥胖是一种在全球范围内日益普遍的疾病。虽然已知遗传和环境因素会调节肥胖及相关代谢疾病的发展,但新出现的研究表明,脂肪组织中的先天性和适应性免疫细胞反应在代谢稳态调节中起着关键作用。在瘦的状态下,2型细胞因子相关的免疫细胞反应在白色脂肪组织中占主导地位,并通过对脂肪细胞的直接作用和诱导米色脂肪来防止体重增加和胰岛素抵抗。在肥胖状态下,这些对代谢有益的免疫途径会失调,脂肪细胞和其他因素会引发对代谢有害的1型炎症,从而损害葡萄糖代谢。本综述讨论了我们目前对不同类型脂肪组织功能的理解,以及免疫细胞在健康和疾病背景下如何调节脂肪细胞功能和代谢稳态,并强调了这一点。我们还强调了将免疫代谢途径作为治疗肥胖及相关疾病的治疗策略的潜力。